Skip to main content
رجوع
Watch Compare

SINOVAC BIOTECH LTD

جودة البيانات: 100%
SVA
Nasdaq Manufacturing Chemicals
KWD 6.47
KWD 0.00 (0.00%)
القيمة السوقية: 642.44 M
السعر
KWD 6.47
القيمة السوقية
642.44 M
نطاق اليوم
KWD 6.47 — KWD 6.47
نطاق 52 أسبوعًا
KWD 6.47 — KWD 6.47
حجم التداول
0
فتح KWD 0.00
متوسط 50 يوم / 200 يوم
KWD 6.47
0.00% above
متوسط 50 يوم / 200 يوم
KWD 6.47
0.00% above

Quick Summary

النقاط الرئيسية

Revenue grew 16.18% annually over 5 years — strong growth
Earnings declined -187.75% over the past year
Debt/Equity of 0.03 — conservative balance sheet
Generating 104.00 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 86.15%

النمو

Revenue Growth (5Y)
16.18%
أعلى من متوسط القطاع (1.82%)
Revenue (1Y)-69.97%
Earnings (1Y)-187.75%
FCF Growth (3Y)-91.57%

الجودة

Return on Equity
-1.13%
أعلى من متوسط القطاع (-53.41%)
ROIC-3.73%
Net Margin-22.29%
Op. Margin-134.52%

الأمان

Debt / Equity
0.03
أقل من متوسط القطاع (0.31)
Current Ratio10.31
Interest Coverage-266.82

التقييم

PE (TTM)
-6.43
أقل من متوسط القطاع (-1.48)
P/B Ratio0.07
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -6.4 -1.5
P/B 0.1 1.6
ROE % -1.1 -53.4
Net Margin % -22.3 -41.5
Rev Growth 5Y % 16.2 1.8
D/E 0.0 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -69.97% Revenue Growth (3Y) -84.79%
Earnings Growth (1Y) -187.75% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 16.18% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 448.27 M Net Income (TTM) -99.92 M
ROE -1.13% ROA -0.72%
Gross Margin 59.51% Operating Margin -134.52%
Net Margin -22.29% Free Cash Flow (TTM) 104.00 M
ROIC -3.73% FCF Growth (3Y) -91.57%
Safety
Debt / Equity 0.03 Current Ratio 10.31
Interest Coverage -266.82 Asset Turnover 0.03
Working Capital 10.68 B Tangible Book Value 8.70 B
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.43 Forward P/E N/A
P/B Ratio 0.07 P/S Ratio 1.43
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 16.19%
Market Cap 642.44 M Enterprise Value -373.79 M
Per Share
EPS (Diluted TTM) -1.06 Revenue / Share 4.51
FCF / Share 1.05 OCF / Share 1.05
EPS CAGR (1Y) -206.00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -104.08%
SBC-Adj. FCF 104.00 M Growth Momentum -86.15

Income Statement

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Revenue 448.27 M 1.49 B 19.37 B 510.62 M 246.05 M
Net Income -99.92 M 113.87 M 8.47 B 110.37 M 44.93 M
EPS (Diluted) -1.06 1.00 74.27 0.97 0.41
Gross Profit 266.75 M 808.31 M 18.30 B 443.44 M 213.58 M
Operating Income -603.02 M -466.07 M 17.55 B 215.64 M 68.56 M
EBITDA — — — — —
R&D Expenses 344.52 M 442.11 M 155.04 M 48.76 M 24.25 M
SG&A Expenses 466.32 M 823.54 M 591.17 M 176.53 M 121.47 M
D&A — — — — —
Interest Expense 2.26 M 1.26 M 2.84 M 1.45 M 650,000.0
Income Tax 105.32 M -62.89 M 3.10 B 31.44 M 5.61 M

Balance Sheet

Annual, most recent first
Metric FY2023 FY2022 FY2021 FY2020 FY2019
Total Assets 13.66 B 14.11 B 16.75 B 1.90 B 452.30 M
Total Liabilities 1.64 B 1.40 B 2.87 B 781.20 M 100.10 M
Shareholders' Equity 8.71 B 8.92 B 9.33 B 746.47 M 294.02 M
Total Debt 253.91 M 11.81 M 15.77 M 35.10 M 5.93 M
Cash & Equivalents 1.27 B 4.28 B 11.61 B 1.04 B 152.72 M
Current Assets 11.83 B 12.13 B 14.92 B 1.56 B 349.61 M
Current Liabilities 1.15 B 1.09 B 2.41 B 679.61 M 87.20 M